What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts ...

Biotech interviews in 2026 demand more than just lab expertise—they assess critical thinking, communication, and the ability to operate within regulatory and fast-paced environments. Employers seek ...

Pharmaceutical stocks are making a comeback as valuations remain attractive and companies successfully address patent cliff concerns, according to UBS global head of biotech research Michael Yee. In ...